ALAN KEN MATSUMOTO M.D. NPI 1043219298

NPI Information

  • NPI: 1043219298
  • Provider Name: ALAN KEN MATSUMOTO, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2730 UNIVERSITY BLVD W
    SUITE 310
    WHEATON, MD
    ZIP 20902
  • Phone: (301) 942-7600

Map and Directions

Get Directions

NPI Details

Alan Ken Matsumoto, M.D. is a rheumatology internal medicine in Wheaton, MD with 41 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Alan Ken Matsumoto, M.D. NPI is 1043219298. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Graduation Year:1985

The provider's business location address is:

2730 UNIVERSITY BLVD W
SUITE 310
WHEATON, MD
ZIP 20902-905
Phone: (301) 942-7600
Fax: (301) 942-3132

The NPI 1043219298 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Vitamin d-3 level (HCPCS:82306)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Therapy procedure using functional activities (HCPCS:97530)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Screening test for antibody to noninfectious agent (HCPCS:86255)
  • Rheumatoid factor level (HCPCS:86431)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • Uric acid level, blood (HCPCS:84550)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Crystal identification from tissue or body fluid (HCPCS:89060)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Body fluid cell count with cell identification (HCPCS:89051)
  • X-ray of both hips, 2 views (HCPCS:73521)
  • Screening test for pathogenic organisms (HCPCS:87081)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Total protein level, urine (HCPCS:84156)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • X-ray of upper spine, 2-3 views (HCPCS:72040)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • X-ray of pelvis, 1-2 views (HCPCS:72170)
  • X-ray of middle spine, 2 views (HCPCS:72070)

The enumeration date for this NPI number is 7/19/2005 and was last updated on 3/11/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyD0036867MARYLANDYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
152147007OTHERMARYLANDCAREFIRST OF MARYLAND
20009OTHERDISTRICT OF COLUMBIACAREFIRST OF DC
30004482962OTHERAETNA
4493058OTHERNCPPO
5090361200MEDICAIDMARYLAND
621470OTHERPRIORITY PARTNERS
7397348OTHERALLIANCE
87169832OTHERMAMSI
91847871OTHERUNITED HEALTHCARE
10103774OTHERFIRST HEALTH

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.